Skip to main content
KMPHARMACEUTICAL Co.,Ltd. logo

KMPHARMACEUTICAL Co.,Ltd. — Investor Relations & Filings

Ticker · 225430 ISIN · KR7225430008 KO Manufacturing
Open in API
Filings indexed 233 across all filing types
Latest filing 2021-03-12 AGM Information
Country KR South Korea
Listing KO 225430

About KMPHARMACEUTICAL Co.,Ltd.

https://en.kmkmp.com/

KMPHARMACEUTICAL Co., Ltd. is a company that develops, manufactures, and distributes personal care products. Its core business areas include oral care solutions, such as toothpaste and toothbrushes; beauty and skincare products; and a dedicated line of items for infants and children. The company leverages its research and development expertise to provide Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM) services, creating customized products tailored to client needs in the oral care and cosmetics sectors. It focuses on developing innovative solutions and adheres to strict quality standards, particularly for its children's product lines.

Recent filings

Filing Released Lang Actions
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal 'Notice of Convocation of General Meeting of Shareholders' (주주총회소집결의) issued by KM Pharmaceutical. It details the date, location, and specific agenda items (financial statement approval, director/auditor appointments, and business purpose amendments) for an upcoming Annual General Meeting. This type of document is provided to shareholders to inform them of the meeting and solicit their votes, which aligns perfectly with the definition of a Proxy Solicitation & Information Statement.
2021-03-12 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a formal 'Notice of General Meeting of Shareholders' (주주총회소집공고) issued by KM Pharmaceutical Co., Ltd. It contains the meeting agenda, date, location, and detailed management reference materials (business overview, industry status, and board activity reports) required for shareholders to make informed voting decisions. This document is a standard proxy statement/notice of meeting sent to shareholders, which falls under the 'Proxy Solicitation & Information Statement' category.
2021-03-12 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (KM Pharmaceutical) disclosing a significant change in revenue or profit structure (30% or more). This type of disclosure is a standard regulatory requirement in the Korean market (DART system) to inform investors of material financial changes before the final audit is completed. Since it provides specific financial highlights and reasons for the change rather than just announcing the release of a report, it falls under the category of Earnings Release (ER) as it serves as the initial announcement of financial performance. FY 2020
2021-02-09 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is specifically used to report insider transactions (purchases or sales of shares by directors or major shareholders). According to the provided definitions, reports of personal share transactions by company directors and executives are classified as 'Director's Dealing' (DIRS).
2021-01-22 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Supervisory Service in South Korea. This type of filing is required when an individual or entity acquires a significant stake (typically 5% or more) in a publicly traded company, or when there is a change in such holdings. In the provided taxonomy, this corresponds to a 'Major Shareholding Notification'.
2021-01-22 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory notice regarding the suspension of share registration (closing of the shareholder register) for the purpose of determining shareholders eligible to vote at the 6th Annual General Meeting. It is a standard corporate governance announcement related to meeting preparation, which fits the 'Regulatory Filings' category as it does not constitute a full report or a specific proxy solicitation document.
2020-12-15 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.